The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...
"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are ...
RNA Drugs: presented yesterday in Naples, at the research area of Naples of the CNR, in via Pietro Castellino, the results of ...
Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...
A long-established drug with a diverse medical history is drawing new attention for its potential role in treating an ultra-rare and life-threatening genetic disorder. Early findings suggest that a me ...
New York Magazine on MSN
Did AI Alter the Course of This Baby’s Life?
When Jorie Kraus was diagnosed with an incurable rare disease, two young researchers created an AI tool to find a treatment.
A mother-of-two has shared the subtle warning sign that lead to both of her children being diagnosed with a rare type of ...
Jinxing Li and Christopher H. Contag delve into magnetobiology, which utilizes magnetic fields to manipulate and control ...
TPAG highlights on urgent, systemic reforms to protect transfusion-dependent patients: Our Bureau, Bengaluru Wednesday, January 14, 2026, 15:15 Hrs [IST] Thalassemia Patients Advo ...
A Northwestern Medicine study published in Nature Communications has revealed how HIV can protect infected cells by altering ...
Soleno Therapeutics leads a rebound in small drug stocks as innovation, pipeline progress and M&A activity fuel optimism for 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback